IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Great Point Partners LLC

Q3 2013 Holdings

Filed 2013-11-14 | 32 holdings | $144.1K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Hyperion Therapeutics IncCOM44915N101$21.5K820,90614.9%
Furiex Pharmaceutical IncCOM36106P101$15.4K349,35610.7%
Ambit Biosciences CorpCOM02318X100$13.7K883,4599.5%
Sunshine Heart IncCOM86782U106$12.6K1,087,9528.7%
Geron Corp(GERN)COM374163103$8.3K2,482,1855.8%
Pain Therapeutics IncCOM69562K100$7.9K2,910,8495.5%
Gentium S P ASPONSORED ADR37250B104$6.1K224,7674.2%
Sophiris BIO IncCOM83578Q209$6.0K1,280,0004.2%
Nanosphere IncCOM63009F105$5.0K2,500,0003.5%
Durata Therapeutics IncCOM26658A107$4.6K508,4723.2%
Heartware Intl IncCOM422368100$4.4K60,0003.0%
Biodel IncCOM NEW09064M204$4.2K1,334,4832.9%
Trinity Biotech PLCSPON ADR NEW896438306$4.1K189,0712.9%
Streamline Health SolutionsCOM86323X106$3.6K475,8782.5%
Volcano CorporationCOM928645100$3.4K142,5002.4%
Amarin Corp PLCCallSPONS ADR NEW23111206$3.2K500,0002.2%
Nordion IncCOM65563C105$2.6K299,9021.8%
Oncogenex Pharmaceutical IncCOM68230A106$2.5K264,6861.7%
Mast Therapeutics IncCOM576314108$2.4K5,442,4001.7%
Given ImagingORD SHSM52020100$2.3K118,0001.6%
RTI Surgical Inc.COM74975N105$2.3K606,0151.6%
Protalix Biotherapeutics IncCOM74365A101$1.8K399,0071.3%
MEI Pharma IncCOM NEW55279B202$1.8K157,6611.2%
Therapeuticsmd IncCOM88338N107$1.2K416,6670.8%
Arqule Inc(ARQLUSD)COM04269E107$871373,9260.6%
Avanir Pharmaceuticals IncCallCL A NEW05348P401$846200,0000.6%
Pernix Therapeutics Hldgs IncCOM71426V108$807296,8110.6%
Horizon Pharma IncCOM44047T109$335100,0000.2%
Alimera Sciences IncCallCOM16259103$27974,3000.2%
Palatin Technologies IncCOM PAR $ .01696077403$133192,9920.1%
GTX Inc delPutCOM40052B108$11757,7000.1%
Wright MED Group IncRIGHT 03/01/201998235T115$41116,6000.0%